tech
April 17, 2026
OpenAI launches GPT-Rosalind, an AI model for life sciences research
Named after the crystallographer who helped reveal the structure of DNA, GPT-Rosalind is OpenAI’s first domain-specific model series, fine-tuned for biochemistry, genomics, and protein engineering. Access is restricted to a trusted-access programme for vetted enterprise customers including Amgen, Moderna, and Thermo Fisher Scientific.
TL;DR
- GPT-Rosalind is OpenAI's first domain-specific AI model series, focused on life sciences.
- It is named after Rosalind Franklin, a key figure in DNA structure discovery.
- The model supports evidence synthesis, hypothesis generation, experimental planning, and scientific workflows in biochemistry, genomics, and protein engineering.
- Access is restricted to a trusted-access program for vetted enterprise customers in the US.
- Launch partners include Amgen, Moderna, Thermo Fisher Scientific, and the Allen Institute.
- GPT-Rosalind demonstrated strong performance on bioinformatics and research task benchmarks, outperforming GPT-5.4 on certain tasks.
- A third-party evaluation showed GPT-Rosalind performing at the 95th percentile of human experts on sequence-to-function prediction tasks.
- Access is restricted due to dual-use concerns regarding the potential misuse of biological data and AI models for designing dangerous pathogens.
Continue reading the original article